A REVIEW OF LENMELDY

The tablet formulation of zanubrutinib (Brukinsa; BeOne) has become approved for all 5 indications across a number of hematological cancers.The modified stem cells provide the body with myeloid (immune) cells that generate the ARSA enzyme, which will help break down the dangerous Establish-up of sulfatides and will end the progression of MLD.  Ahe